九安醫療(002432.SZ):半年度淨利潤預增46.24%-62.86%
格隆匯7月14日丨九安醫療(002432.SZ)公佈2025年半年度業績預告,1-6月公司實現歸屬上市公司股東的淨利潤盈利8.8億元-9.8億元,比上年同期增長46.24%-62.86%;扣除非經營性損益的淨利潤盈利8.6億元-9.6億元,比上年同期增長23.29%-37.63%;基本每股收益盈利2.0129元/股-2.2416元/股。
公司報告期淨利潤較去年同期大幅增長,主要系報告期公司資產管理業務的大類資產配置表現較好,公司以投資業務爲主營業務的子公司作爲投資主體,其投資活動系正常經營業務,投資業務形成的投資收益及公允價值變動收益作爲經常性損益列示。公司以全球化大類資產配置視角,進行多元化分散資產管理,爲公司提供了堅實的資金和經營的保障,公司致力於資產的保值增值,風險抵禦能力持續提高。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.